How sequencing and PCR work together in oncology research

In this episode of Absolute Gene-ius, the hosts dive into the evolving world of precision oncology, where detecting rare molecular signals can make all the difference. Dr. Kathie Sollweck brings deep expertise from her work in medical affairs and oncology to explain how modern molecular tools are reshaping cancer research. She breaks down liquid biopsy approaches, including cell-free DNA and circulating tumor cells, and explains why sensitivity and pre-analytics are critical when working with low-abundance targets. Kathie also clarifies how sequencing acts as a wide-angle discovery tool, while digital PCR serves as a laser-focused method for ultra-sensitive monitoring of known mutations, therapy resistance, and minimal residual disease (MRD). Together, these technologies enable more personalized, precise, and less invasive cancer researh strategies. The episode wraps with a fun and refreshingly honest Career Corner, where Kathie shares her non-linear journey from an aspiring actress to botanist to oncology expert. Her advice? Don’t fear sales roles, stay open to unexpected opportunities, and let curiosity guide your career because you never know where it might take you. Visit the Absolute Gene-ius page to learn more about the guests, the hosts, and the science we explore. Discover the Applied Biosystems QuantStudio Digital and Real-Time PCR Systems powering real-world research across neuroscience, oncology, agriculture, and more.